Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial cell membrane and bacterial cell wall are fundamental structural components that define the boundary and maintain the viability of bacterial cells. The bacterial cell wall is primarily composed of peptidoglycan, a complex polymer that provides mechanical strength and protects the cell from high internal osmotic pressure; it is a classic target for beta-lactam antibiotics and glycopeptides (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). The microbial cell membrane, situated beneath the cell wall, is a phospholipid bilayer that regulates the transport of nutrients and waste while serving as a scaffold for essential metabolic processes like ATP synthesis. These structures are highly effective therapeutic targets because their composition—such as the presence of peptidoglycan or specific lipopolysaccharides—is unique to microbes, allowing for selective toxicity with minimal impact on human host cells (Kohanski et al., 2010, Nat Rev Microbiol). Drugs targeting the cell wall, like penicillins, inhibit the cross-linking of peptidoglycan strands, leading to cell lysis, while membrane-active agents like polymyxins act as surfactants to disrupt membrane stability (Sizar & Unakal, 2023, StatPearls). Despite their success as targets, the evolution of resistance mechanisms, including target site modification and the production of degradative enzymes like beta-lactamases, continues to challenge the efficacy of drugs hitting these structures.
Inhibition of peptidoglycan synthesis by binding to penicillin-binding proteins (PBPs); inhibition of cell wall synthesis by binding to D-alanyl-D-alanine precursors; disruption of membrane integrity through pore formation or detergent-like action; inhibition of lipid carrier recycling.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and bacterial cell wall.